Afimkibart (WT IgG1)
Based on 1 publication(s) in Google Scholar
Afimkibart (PF-06480605; RVT-3101) is a fully human monoclonal antibody that selectively inhibits trimeric tumor necrosis factor-like ligand 1A (TL1A). Afimkibart neutralizes active trimeric TL1A, blocks TL1A-induced signaling pathways. Afimkibart inhibits NF-κB activation and IFN-γ production. Afimkibart can be used for the research of inflammatory bowel disease.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.59%
- CAS 番号: 2911580-96-4
- 分子量:146.54 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
MedChemExpress(MCE)の使用を引用している文献 Afimkibart (WT IgG1)
More
生物活性
製品説明
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
TL1A |
体外実験
Afimkibart selectively binds to functionally active trimeric recombinant human TL1A and does not bind to monomeric recombinant human TL1A[1].
Afimkibart potently inhibits trimeric recombinant human TL1A-induced NF-κB activation in human peripheral T lymphocytes and trimeric recombinant human TL1A/IL12/IL18-induced IFN-γ production in human PBMCs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
遺伝子ID
アクセッション番号
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized TL1A/TNFSF15 Trimer Protein, Human can bind Afimkibart. The EC50 for this effect is 8.563 ng/mL. -
Flow cytometric analysis of 1.5X106 HT-29 cells with Afimkibart (HY-P990876, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa, Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
化学情報
-
CAS 番号 2911580-96-4
-
性状 Liquid
-
分子量 146.54 kDa
-
Color Colorless to light yellow
-
SMILES
[Afimkibart (WT IgG1)]
-
別名
PF-06480605 (WT IgG1); RVT-3101 (WT IgG1)
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Inflamm Bowel Dis
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. [Abstract]2026 Jun 27:izag101. PMID: 42364076
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Afimkibart (WT IgG1)
- 2911580-96-4
- PF-06480605 (WT IgG1)
- RVT-3101 (WT IgG1)
- TNF Receptor
- NF-κB
- IFNAR
- peripheral T lymphocytes
- IFN-γ
- endogenous active TL1A
- TL1A
- Tumor necrosis factor-like ligand 1A
- inflammatory bowel disease
- human peripheral blood mononuclear cells
- interferon-gamma
- human PBMCs
- Inhibitor
- inhibitor
- inhibit